BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16427141)

  • 1. Cognitive impairment but preservation of sexual dimorphism in cognitive abilities in chronic schizophrenia.
    Halari R; Mehrotra R; Sharma T; Ng V; Kumari V
    Psychiatry Res; 2006 Feb; 141(2):129-39. PubMed ID: 16427141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in neuropsychological functioning among schizophrenia patients.
    Bozikas VP; Kosmidis MH; Peltekis A; Giannakou M; Nimatoudis I; Karavatos A; Fokas K; Garyfallos G
    Aust N Z J Psychiatry; 2010 Apr; 44(4):333-41. PubMed ID: 20050721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurocognitive subtypes of schizophrenia according to performance at verbal fluency tasks].
    Robert PH; Thauby S; Migneco V; Chaix I; Caci H; Benoit M; Pringuey D; Darcourt G
    Encephale; 1996; 22(6):435-42. PubMed ID: 10901836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Tunisian cognitive battery for patients with schizophrenia].
    Ben Azouz O; Dellagi L; Kebir O; Johnson I; Amado I; Tabbane K
    Tunis Med; 2009 Oct; 87(10):674-9. PubMed ID: 20187356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between cognitive defects and the course of schizophrenia. Initial study of a rehabilitation programme participants].
    Hanuszkiewicz I; Cechnicki A; Kalisz A
    Psychiatr Pol; 2007; 41(4):539-50. PubMed ID: 18046984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
    White T; Ho BC; Ward J; O'Leary D; Andreasen NC
    Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences and individual differences in cognitive performance and their relationship to endogenous gonadal hormones and gonadotropins.
    Halari R; Hines M; Kumari V; Mehrotra R; Wheeler M; Ng V; Sharma T
    Behav Neurosci; 2005 Feb; 119(1):104-17. PubMed ID: 15727517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Barcelona Test for cognitive assessment of patients with schizophrenia.
    Gil D; Bengochea R; Arrieta M; Lastra I; Sánchez R; Alvarez A; Diego M; Prat R
    Actas Esp Psiquiatr; 2008; 36(6):337-44. PubMed ID: 18781409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatological and cognitive predictors of insight in chronic schizophrenia.
    Nakano H; Terao T; Iwata N; Hasako R; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):65-72. PubMed ID: 15261706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals.
    Pietrzak RH; Snyder PJ; Jackson CE; Olver J; Norman T; Piskulic D; Maruff P
    Hum Psychopharmacol; 2009 Mar; 24(2):113-21. PubMed ID: 19090506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.
    O'Hara R; Sommer B; Way N; Kraemer HC; Taylor J; Murphy G
    J Psychiatr Res; 2008 Feb; 42(3):199-204. PubMed ID: 17250852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
    J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological profile of cognitively impaired patients with schizophrenia.
    Bozikas VP; Kosmidis MH; Kiosseoglou G; Karavatos A
    Compr Psychiatry; 2006; 47(2):136-43. PubMed ID: 16490572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and cognitive correlates of formal thought disorder in early onset schizophrenia.
    Remberk B; Namysłowska I; Rybakowski F
    Neuro Endocrinol Lett; 2012; 33(3):347-55. PubMed ID: 22635096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients.
    Bora E; Vahip S; Akdeniz F; Gonul AS; Eryavuz A; Ogut M; Alkan M
    Bipolar Disord; 2007 Aug; 9(5):468-77. PubMed ID: 17680917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonepisodic memory deficits in amnestic MCI.
    Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
    Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.